ZNF653
gene geneOn this page
Also known as Zip67
Summary
ZNF653 (zinc finger protein 653, HGNC:25196) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 653 (Q96CK0). Transcriptional repressor.
Enables AF-2 domain binding activity; DNA-binding transcription factor binding activity; and transcription corepressor activity. Involved in extracellular negative regulation of signal transduction and negative regulation of transcription by RNA polymerase II. Predicted to be located in extracellular region. Predicted to be active in nucleus.
Source: NCBI Gene 115950 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 86 total
- MANE Select transcript:
NM_138783
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25196 |
| Approved symbol | ZNF653 |
| Name | zinc finger protein 653 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Zip67 |
| Ensembl gene | ENSG00000161914 |
| Ensembl biotype | protein_coding |
| OMIM | 611371 |
| Entrez | 115950 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000293771, ENST00000588541, ENST00000589051, ENST00000590296, ENST00000590548, ENST00000592756, ENST00000593191, ENST00000937056
RefSeq mRNA: 1 — MANE Select: NM_138783
NM_138783
CCDS: CCDS12261
Canonical transcript exons
ENST00000293771 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001061335 | 11486987 | 11487158 |
| ENSE00001061344 | 11487292 | 11487903 |
| ENSE00001248971 | 11505488 | 11505839 |
| ENSE00003479594 | 11483429 | 11483859 |
| ENSE00003483059 | 11498296 | 11498339 |
| ENSE00003527610 | 11485656 | 11485770 |
| ENSE00003528709 | 11486769 | 11486880 |
| ENSE00003591427 | 11495950 | 11496165 |
| ENSE00003683840 | 11484042 | 11484141 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 92.50.
FANTOM5 (CAGE): breadth broad, TPM avg 0.6170 / max 38.9323, expressed in 343 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179246 | 0.6170 | 343 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 92.50 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 92.15 | gold quality |
| cerebellar cortex | UBERON:0002129 | 91.96 | gold quality |
| cerebellum | UBERON:0002037 | 90.50 | gold quality |
| left testis | UBERON:0004533 | 90.03 | gold quality |
| right testis | UBERON:0004534 | 89.92 | gold quality |
| testis | UBERON:0000473 | 86.65 | gold quality |
| right frontal lobe | UBERON:0002810 | 86.53 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 85.00 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 84.24 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 84.11 | gold quality |
| prefrontal cortex | UBERON:0000451 | 84.08 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 83.86 | gold quality |
| cortical plate | UBERON:0005343 | 83.82 | gold quality |
| adenohypophysis | UBERON:0002196 | 82.24 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 82.04 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 81.87 | gold quality |
| popliteal artery | UBERON:0002250 | 81.84 | gold quality |
| tibial artery | UBERON:0007610 | 81.84 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 81.83 | gold quality |
| granulocyte | CL:0000094 | 81.60 | gold quality |
| hypothalamus | UBERON:0001898 | 80.93 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.80 | gold quality |
| body of stomach | UBERON:0001161 | 80.69 | gold quality |
| caudate nucleus | UBERON:0001873 | 80.50 | gold quality |
| right adrenal gland | UBERON:0001233 | 80.44 | gold quality |
| neocortex | UBERON:0001950 | 80.44 | gold quality |
| aorta | UBERON:0000947 | 80.43 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 80.40 | gold quality |
| pituitary gland | UBERON:0000007 | 80.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.55 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| CDKN2A |
miRNA regulators (miRDB)
11 targeting ZNF653, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-216A-5P | 99.50 | 68.02 | 1288 |
| HSA-MIR-3196 | 98.96 | 63.91 | 326 |
| HSA-MIR-3180 | 98.46 | 64.68 | 348 |
| HSA-MIR-3180-3P | 98.46 | 64.68 | 348 |
| HSA-MIR-6816-5P | 98.46 | 64.35 | 364 |
| HSA-MIR-6787-5P | 97.54 | 63.85 | 457 |
| HSA-MIR-10396B-5P | 94.99 | 63.57 | 358 |
| HSA-MIR-1908-5P | 94.99 | 63.41 | 352 |
| HSA-MIR-663A | 94.99 | 63.54 | 378 |
| HSA-MIR-6812-3P | 90.58 | 63.80 | 60 |
Literature-anchored findings (GeneRIF, showing 1)
- novel zinc-finger protein that influences gene activation through interaction with the functionally important activation function-2 domain of nuclear receptors (PMID:12920234)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf653 | ENSDARG00000093469 |
| mus_musculus | Zfp653 | ENSMUSG00000038895 |
| rattus_norvegicus | Zfp653 | ENSRNOG00000014065 |
Paralogs (36): ZBTB32 (ENSG00000011590), SNAI2 (ENSG00000019549), PRDM1 (ENSG00000057657), PRDM6 (ENSG00000061455), ZNF76 (ENSG00000065029), PATZ1 (ENSG00000100105), MAZ (ENSG00000103495), ZBTB16 (ENSG00000109906), ZNF451 (ENSG00000112200), ZBTB45 (ENSG00000119574), ZNF410 (ENSG00000119725), SNAI1 (ENSG00000124216), ZNF384 (ENSG00000126746), ZBTB1 (ENSG00000126804), VEZF1 (ENSG00000136451), PRDM14 (ENSG00000147596), ZNF276 (ENSG00000158805), ZNF362 (ENSG00000160094), ZNF281 (ENSG00000162702), ZNF148 (ENSG00000163848), ZNF143 (ENSG00000166478), HIC2 (ENSG00000169635), PRDM10 (ENSG00000170325), ZNF296 (ENSG00000170684), ZNF692 (ENSG00000171163), ZNF575 (ENSG00000176472), HIC1 (ENSG00000177374), ZBTB18 (ENSG00000179456), ZBTB42 (ENSG00000179627), ZBTB20 (ENSG00000181722), ZBTB7C (ENSG00000184828), SNAI3 (ENSG00000185669), ZFP91 (ENSG00000186660), MTF1 (ENSG00000188786), SCRT2 (ENSG00000215397), SCRT1 (ENSG00000261678)
Protein
Protein identifiers
Zinc finger protein 653 — Q96CK0 (reviewed: Q96CK0)
Alternative names: 67 kDa zinc finger protein, Zinc finger protein Zip67
All UniProt accessions (5): Q96CK0, K7EJG9, K7EKL4, K7EL79, K7ENS4
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor. May repress NR5A1, PPARG, NR1H3, NR4A2, ESR1 and NR3C1 transcriptional activity.
Subunit / interactions. Interacts with NR5A1.
Subcellular location. Nucleus.
Tissue specificity. Highly expressed in testis, cerebellum, temporal lobe, hippocampus and the adrenal gland. Moderately expressed in spleen, uterus, thymus, pancreas, kidney, stomach and rectum.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_620138* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR051061 |
Pfam: PF00096
UniProt features (18 total): zinc finger region 5, compositionally biased region 4, region of interest 4, short sequence motif 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96CK0-F1 | 50.06 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 73 (showing top):
TGCGCANK_UNKNOWN, E2F_Q3, GOBP_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION, TGAGATT_MIR216, E2F1_Q3, NRF2_01, RASHI_RESPONSE_TO_IONIZING_RADIATION_6, chr19p13, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GOMF_TRANSCRIPTION_FACTOR_BINDING, GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY, ELK1_02, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, BAKKER_FOXO3_TARGETS_DN
GO Biological Process (5): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), extracellular negative regulation of signal transduction (GO:1900116), regulation of macromolecule metabolic process (GO:0060255), regulation of primary metabolic process (GO:0080090)
GO Molecular Function (8): DNA binding (GO:0003677), transcription coregulator activity (GO:0003712), transcription corepressor activity (GO:0003714), zinc ion binding (GO:0008270), AF-2 domain binding (GO:0050682), DNA-binding transcription factor binding (GO:0140297), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): extracellular region (GO:0005576), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| negative regulation of DNA-templated transcription | 2 |
| regulation of metabolic process | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| regulation of DNA-templated transcription | 1 |
| extracellular region | 1 |
| negative regulation of signal transduction | 1 |
| extracellular regulation of signal transduction | 1 |
| macromolecule metabolic process | 1 |
| primary metabolic process | 1 |
| nucleic acid binding | 1 |
| transcription regulator activity | 1 |
| transcription coregulator activity | 1 |
| transition metal ion binding | 1 |
| protein domain specific binding | 1 |
| transcription factor binding | 1 |
| binding | 1 |
| cation binding | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
656 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF653 | NR5A2 | O00482 | 761 |
| ZNF653 | RNF166 | Q96A37 | 637 |
| ZNF653 | NCOA2 | Q15596 | 632 |
| ZNF653 | CRBN | Q96SW2 | 624 |
| ZNF653 | NR5A1 | Q13285 | 593 |
| ZNF653 | NCOA1 | Q15788 | 587 |
| ZNF653 | RAB28 | P51157 | 570 |
| ZNF653 | DTWD1 | Q8N5C7 | 480 |
| ZNF653 | LMBRD2 | Q68DH5 | 475 |
| ZNF653 | GSPT1 | P15170 | 447 |
| ZNF653 | SACK1F | Q8NEG4 | 445 |
| ZNF653 | DCAF6 | Q58WW2 | 432 |
| ZNF653 | TTLL5 | Q6EMB2 | 424 |
| ZNF653 | UBA3 | Q8TBC4 | 406 |
| ZNF653 | NAE1 | Q13564 | 395 |
IntAct
19 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP76 | ZNF653 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM41 | ZNF653 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LONRF1 | ZNF653 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAPRE1 | ZNF653 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF653 | H2BC12L | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF653 | HMGN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF653 | HIST2H2BF | psi-mi:“MI:0915”(physical association) | 0.400 |
| CTBP1 | TAF15 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC16A11 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF653 | URB1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF653 | CEP76 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF653 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LONRF1 | ZNF653 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAPRE1 | ZNF653 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (53): ZNF653 (Two-hybrid), ZNF653 (Reconstituted Complex), ZNF653 (Two-hybrid), ZNF653 (Two-hybrid), ZNF653 (Two-hybrid), ZNF653 (Two-hybrid), ZNF653 (Proximity Label-MS), ZNF653 (Proximity Label-MS), ZNF653 (Proximity Label-MS), ZNF653 (Two-hybrid), ZNF653 (Two-hybrid), ZNF653 (Affinity Capture-RNA), THUMPD3 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), YEATS2 (Affinity Capture-MS)
ESM2 similar proteins: A2A5K6, F1QQA8, G3V893, O08696, O14901, O57415, P36197, P37275, P97691, Q04891, Q07243, Q08050, Q14872, Q16254, Q2QGD7, Q3UH06, Q5EAC5, Q5F293, Q60542, Q62255, Q62947, Q64318, Q66K89, Q6DBW0, Q6YND2, Q7TS63, Q80X44, Q86V15, Q86VK4, Q8BG87, Q8BKX7, Q8BX22, Q8C8V1, Q8CCE9, Q8IVH2, Q91X45, Q92766, Q96CK0, Q99607, Q9BYN7
Diamond homologs: A0JC51, A2ANX9, O15391, O57311, O57415, O60481, O62836, O73689, O95409, P08048, P0C6P6, P10925, P17010, P17012, P18747, P20662, P22227, P25490, P34694, P46684, P80944, Q00899, Q10RP4, Q12145, Q15915, Q29419, Q2FAY8, Q3TTC2, Q3UH06, Q3US17, Q3Y4E1, Q52V16, Q5NVT2, Q5R782, Q5RJ54, Q61467, Q61624, Q62520, Q62521, Q62806
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
86 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 73 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1485 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:11483870:CCCG:C | acceptor_gain | 1.0000 |
| 19:11483872:C:T | acceptor_gain | 1.0000 |
| 19:11484038:TCA:T | donor_loss | 1.0000 |
| 19:11484039:CAC:C | donor_loss | 1.0000 |
| 19:11484040:A:AC | donor_gain | 1.0000 |
| 19:11484040:ACTG:A | donor_gain | 1.0000 |
| 19:11484041:C:CT | donor_gain | 1.0000 |
| 19:11484041:CTG:C | donor_gain | 1.0000 |
| 19:11484041:CTGC:C | donor_gain | 1.0000 |
| 19:11484138:ACACC:A | acceptor_loss | 1.0000 |
| 19:11484139:CAC:C | acceptor_gain | 1.0000 |
| 19:11484139:CACCT:C | acceptor_loss | 1.0000 |
| 19:11484140:ACCTG:A | acceptor_loss | 1.0000 |
| 19:11484141:CCT:C | acceptor_loss | 1.0000 |
| 19:11484143:T:A | acceptor_loss | 1.0000 |
| 19:11485650:CCTGA:C | donor_loss | 1.0000 |
| 19:11485651:CTGA:C | donor_loss | 1.0000 |
| 19:11485651:CTGAC:C | donor_loss | 1.0000 |
| 19:11485652:TGA:T | donor_loss | 1.0000 |
| 19:11485652:TGAC:T | donor_loss | 1.0000 |
| 19:11485653:GACCT:G | donor_loss | 1.0000 |
| 19:11485654:ACC:A | donor_loss | 1.0000 |
| 19:11485655:CCTG:C | donor_loss | 1.0000 |
| 19:11486763:CCTCA:C | donor_loss | 1.0000 |
| 19:11486764:CTCA:C | donor_loss | 1.0000 |
| 19:11486765:TCA:T | donor_loss | 1.0000 |
| 19:11486766:CAC:C | donor_loss | 1.0000 |
| 19:11486767:ACCTG:A | donor_loss | 1.0000 |
| 19:11486768:C:CT | donor_loss | 1.0000 |
| 19:11486878:CTC:C | acceptor_gain | 1.0000 |
AlphaMissense
4011 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:11483720:G:C | H604D | 1.000 |
| 19:11483759:A:G | C591R | 1.000 |
| 19:11483768:A:G | C588R | 1.000 |
| 19:11483818:A:G | L571P | 1.000 |
| 19:11483848:C:T | C561Y | 1.000 |
| 19:11483849:A:G | C561R | 1.000 |
| 19:11483858:A:G | C558R | 1.000 |
| 19:11484062:G:C | H550Q | 1.000 |
| 19:11484062:G:T | H550Q | 1.000 |
| 19:11484076:G:C | H546D | 1.000 |
| 19:11484076:G:T | H546N | 1.000 |
| 19:11484084:A:G | L543P | 1.000 |
| 19:11484101:G:C | F537L | 1.000 |
| 19:11484101:G:T | F537L | 1.000 |
| 19:11484102:A:G | F537S | 1.000 |
| 19:11484103:A:G | F537L | 1.000 |
| 19:11484114:C:T | C533Y | 1.000 |
| 19:11484124:A:G | C530R | 1.000 |
| 19:11484128:G:C | F528L | 1.000 |
| 19:11484128:G:T | F528L | 1.000 |
| 19:11484130:A:G | F528L | 1.000 |
| 19:11485672:G:C | H518Q | 1.000 |
| 19:11485672:G:T | H518Q | 1.000 |
| 19:11485674:G:T | H518N | 1.000 |
| 19:11485682:A:G | L515P | 1.000 |
| 19:11485699:G:C | F509L | 1.000 |
| 19:11485699:G:T | F509L | 1.000 |
| 19:11485700:A:G | F509S | 1.000 |
| 19:11485701:A:G | F509L | 1.000 |
| 19:11485711:A:C | C505W | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000018285 (19:11494860 G>A), RS1000046368 (19:11489207 G>A,C,T), RS1000294178 (19:11505624 ACTT>A), RS1000329578 (19:11499956 T>C), RS1000341825 (19:11494639 G>A), RS1000418373 (19:11483580 G>A,C), RS1000478759 (19:11505675 G>T), RS1000496818 (19:11504438 C>A), RS1000578949 (19:11505421 C>A,G,T), RS1000707925 (19:11485944 G>T), RS1000734544 (19:11498542 C>T), RS1000764300 (19:11498220 C>A,T), RS1000843071 (19:11489290 C>G), RS1001033010 (19:11499594 A>C), RS1001144822 (19:11489558 C>T)
Disease associations
OMIM: gene MIM:611371 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003563_11 | Presence of antiphospholipid antibodies | 3.000000e-06 |
| GCST003563_12 | Presence of antiphospholipid antibodies | 4.000000e-06 |
| GCST003563_6 | Presence of antiphospholipid antibodies | 5.000000e-08 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, increases mutagenesis | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| pomalidomide | decreases expression, increases degradation | 1 |
| clothianidin | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Cisplatin | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.